Multistream Deep Learning Models Using Multimodal Optical Coherence Tomography for Predicting Visual Impairment in Epiretinal Membrane.
Yeh et al.
Am J Ophthalmol·Feb 1, 2026
A multistream deep learning model integrating eight types of OCT imaging modalities achieved 80% accuracy in predicting visual impairment (≤20/50) in patients with epiretinal membrane, outperforming single-modality models.
Peripapillary Retinoschisis: The Expanded Spectrum and New Insights From Multimodal Imaging.
Yang et al.
Am J Ophthalmol·Feb 1, 2026
This multicenter study of 47 eyes identified 9 distinct etiologies of peripapillary retinoschisis (PPRS), establishing a comprehensive classification system and introducing a new entity called 'Focal Optic Disc Dome' (FODD).
VISUAL AND ANATOMIC OUTCOMES OF VITRECTOMY FOR MYOPIC MACULOSCHISIS WITH AND WITHOUT MACULAR DETACHMENT: A Case-Control Study.
Li et al.
Retina·Feb 1, 2026
In myopic maculoschisis patients undergoing pars plana vitrectomy, the presence of concurrent macular detachment did not significantly affect postoperative visual or anatomical outcomes, with both groups achieving similar final visual acuity and foveal relief rates.
INNER FOVEAL IRREGULARITIES AFTER VITREOMACULAR DETACHMENT: A Morphologic Risk Factor for Macular Hole Formation in the Fellow Eye.
Klaas et al.
Retina·Feb 1, 2026
Inner foveal irregularities (IFI) identified on OCT after vitreomacular detachment are a significant morphologic risk factor for full-thickness macular hole development in fellow eyes, with a 44.4% cumulative risk at 24 months.
PORES IN THE RETINAL INNER LIMITING MEMBRANE FORMED BY MÜLLER CELL PROTRUSIONS.
Vogt et al.
Retina·Feb 1, 2026
Advanced electron microscopy reveals that inner limiting membrane (ILM) pores are formed by Müller cell processes protruding through the ILM, potentially contributing to epiretinal membrane formation.
HYPERREFLECTIVE RETINAL SPOTS IN EPIRETINAL MEMBRANES: Evolving Significance Across Disease Stages.
Quarta et al.
Retina·Feb 1, 2026
Hyperreflective spots (HRS) on OCT increase with epiretinal membrane severity and correlate with visual acuity in early stages (1-2) but lose this predictive value in advanced stages (3-4).
PROGNOSTIC FACTORS FOR DEVELOPMENT OF GLIOSIS AFTER INTERNAL LIMITED MEMBRANE FLAP FOR IDIOPATHIC MACULAR HOLES.
Barayev et al.
Retina·Feb 1, 2026
Gliosis develops in 12.3% of patients after macular hole surgery with ILM flap technique, primarily in cases with larger baseline hole diameter and worse preoperative visual acuity.
HEAVY VERSUS STANDARD SILICONE OIL TAMPONADE IN PRIMARY RETINAL DETACHMENT SURGERY: A Systematic Review and Meta-Analysis.
Carlà et al.
Retina·Feb 1, 2026
This meta-analysis of 984 eyes found that heavy silicone oil (HSO) and standard silicone oil (SSO) achieve comparable anatomical success rates and visual outcomes in primary rhegmatogenous retinal detachment surgery, but HSO is associated with significantly higher rates of IOP elevation and emulsification.
EVALUATING POSTERIOR VITREOUS DETACHMENT ANNOTATION CONSISTENCY ON OPTICAL COHERENCE TOMOGRAPHY SCANS IN PATIENTS WITH DISEASE OF THE VITREOMACULAR INTERFACE.
Ferro Desideri et al.
Retina·Feb 1, 2026
Six experienced ophthalmologists showed only moderate agreement (κ=0.57) when classifying posterior vitreous detachment on SD-OCT in patients with epiretinal membrane and macular hole, with particularly poor agreement for completely attached vitreous cases.
Relative Risk of Retinal Detachment in COL2A1 Compared with COL11A1 Stickler Syndrome: An Individual Patient Data Meta-Analysis.
Carpenter et al.
Ophthalmol Retina·Feb 1, 2026
This meta-analysis of 673 Stickler syndrome patients found that COL2A1 variants carry a 1.78-fold higher risk of retinal detachment compared to COL11A1 variants (47% vs 28% incidence).
Racial and Ethnic Disparities in Risk for Adverse Ocular Events in Patients With Diabetic Retinopathy.
Anozie et al.
Am J Ophthalmol·Feb 1, 2026
This retrospective study of 627,434 diabetic retinopathy patients found significant racial disparities, with Black and Hispanic patients experiencing substantially higher risks of blindness, vitreous hemorrhage, tractional retinal detachment, and diabetic macular edema compared to other racial groups.
Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-Pan-Retinal Photocoagulation.
He et al.
Am J Ophthalmol·Feb 1, 2026
This prospective study using ultrawide-field swept-source OCTA reveals that pan-retinal photocoagulation (PRP) works through a dual mechanism: direct thermal damage reducing choroidal vascularity and adaptive compensation via choroidal-derived intraretinal neovascularization (CDIRN) at 72.5% of laser scars.
Association of OCT Angiography-Detected Intraretinal Microvascular Abnormalities with Diabetic Retinopathy Severity.
Ding et al.
Ophthalmol Retina·Feb 1, 2026
This study demonstrates that intraretinal microvascular abnormalities (IRMAs) detected on swept-source OCT angiography are strongly associated with diabetic retinopathy severity, with specific morphological subtypes and distribution patterns serving as predictors of severe NPDR.
Noninvasive Synthesis of Multiframe Ultra-Widefield Fluorescein Angiography from Color Fundus Photographs.
Chen et al.
Ophthalmol Retina·Feb 1, 2026
Researchers developed a generative AI model that creates realistic ultra-widefield fluorescein angiography images from color fundus photographs without requiring IV dye injection, significantly improving diabetic retinopathy screening accuracy.
Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide.
Barkmeier et al.
Ophthalmol Retina·Feb 1, 2026
This large retrospective study found no significant differences in sight-threatening diabetic retinopathy risk among different GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide, and exenatide) in patients with type 2 diabetes at moderate cardiovascular risk.
EXUDATIVE MACULAR NEOVASCULARIZATION BEFORE VISIBLE PIGMENTATION IN MACULAR TELANGIECTASIA TYPE-2 (MacTel).
Chandran et al.
Retina·Feb 1, 2026
In MacTel type-2, exudative macular neovascularization (ExMNV) can develop directly without preceding pigmentation in 2% of cases, bypassing the typical disease progression pattern.
Oral Acetylcysteine and the Risk of Age-Related Macular Degeneration: A Retrospective Cohort Study.
Tsai et al.
Ophthalmology·Feb 1, 2026
This retrospective cohort study of 10,468 Taiwanese patients found that oral N-acetylcysteine (NAC) use was associated with an 81% reduction in overall AMD risk, with stronger protective effects against dry AMD than wet AMD.
TYPE 4 MACULAR NEOVASCULARIZATION: A New Member of the Optical Coherence Tomography Classification of Neovascularization Age-Related Macular Degeneration.
Chan et al.
Retina·Feb 1, 2026
Researchers identified Type 4 macular neovascularization (MNV) as a new, aggressive AMD phenotype characterized by mixed Type 1/2 neovascularization with extensive intraretinal anastomotic networks and poor visual outcomes despite anti-VEGF therapy.
Long-Term Metformin Use and Reduced Risk of Age-Related Macular Degeneration: A Large Database Study.
Hong et al.
Ophthalmol Retina·Feb 1, 2026
Long-term metformin use (≥5 years) in diabetic patients aged ≥60 was associated with a 32% reduced risk of developing age-related macular degeneration compared to non-users.
Randomized Trial of Biosimilar ABP 938 Compared with Reference Aflibercept in Adults with Neovascular Age-Related Macular Degeneration.
Friedman et al.
Ophthalmol Retina·Feb 1, 2026
A randomized controlled trial of 579 treatment-naïve nAMD patients demonstrated that biosimilar ABP 938 is clinically equivalent to reference aflibercept, with no meaningful differences in efficacy, safety, or immunogenicity.
Risk of Alzheimer Disease and Related Dementia after Retinal Vascular Occlusion: A Nationwide Cohort Analysis.
Tsai et al.
Ophthalmol Retina·Feb 1, 2026
This large nationwide cohort study of nearly 40,000 patients found that retinal vascular occlusion is associated with a 57-76% increased risk of developing Alzheimer disease and related dementias.
SYSTEMIC THROMBOEMBOLIC OUTCOMES IN YOUNG PATIENTS AFTER RETINAL VEIN OCCLUSIONS.
Zhang et al.
Retina·Feb 1, 2026
Young patients (18-50 years) with retinal vein occlusions but no identifiable risk factors have significantly increased long-term risk of venous thromboembolism and stroke compared to matched controls, but not myocardial infarction.
THE ROLE OF EN FACE IMAGING OF RETINAL PIGMENT EPITHELIUM ALTERATIONS IN RAPID CLASSIFICATION OF CENTRAL SEROUS CHORIORETINOPATHY USING WIDEFIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.
Zhang et al.
Retina·Feb 1, 2026
Widefield en face OCT imaging of RPE alterations demonstrates high sensitivity (88.2%) for detecting complex CSCR and offers a reliable, noninvasive method for rapid CSCR classification.
FREQUENCY OF MISDIAGNOSES AND ASSOCIATED RISK FACTORS IN MACULAR TELANGIECTASIA TYPE 2.
Raming et al.
Retina·Feb 1, 2026
Misdiagnosis occurs in 35.8% of macular telangiectasia type 2 (MacTel) cases, with delays in correct diagnosis averaging 38.5 months, though diagnostic accuracy has improved significantly since 2020.
LARGE RETINAL CAPILLARY ANEURYSM: Clinical Features, Multimodal Imaging Characteristics, and Treatment Outcomes of Primary and Secondary Lesions.
Tekin et al.
Retina·Feb 1, 2026
This comparative study of 34 eyes with large retinal capillary aneurysms found that primary and secondary lesions have similar imaging characteristics, but secondary LRCAs show significantly better treatment responses and visual outcomes compared to primary lesions.
The Association between Retinal Vascular Occlusions and Dementia: A UK Biobank Retrospective Longitudinal Study.
Gao et al.
Ophthalmol Retina·Feb 1, 2026
This UK Biobank study of over 500,000 participants found that retinal vascular occlusions were associated with increased dementia risk, but this association disappeared after adjusting for shared cardiovascular risk factors.
Unveiling Inflammation-Like Retinal Remodeling in CRB1-Associated Inherited Retinal Dystrophies: Insights From a Multicenter Study.
Hong et al.
Am J Ophthalmol·Feb 1, 2026
This multicenter study of 66 CRB1-associated inherited retinal dystrophy patients identified inflammatory-like fundus features as core characteristics, with preserved para-arteriolar RPE being the most common finding (77.5%) and severity correlating with genotype.
Central Retinal Sensitivity Decline in RPGR-Related Retinal Phenotypes.
Josan et al.
Am J Ophthalmol·Feb 1, 2026
CORD patients with RPGR mutations experience significantly faster central retinal sensitivity decline compared to rod-cone dystrophy patients, with 2-3 times higher annual decline rates and earlier median survival to total central vision loss.
CONTRAST SENSITIVITY FUNCTION CORRELATES WITH OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN MACULAR TELANGIECTASIA TYPE 2.
Finn et al.
Retina·Feb 1, 2026
Quantitative contrast sensitivity function testing reveals significantly reduced contrast sensitivity across spatial frequencies in macular telangiectasia type 2 eyes compared to controls, with changes correlating with early structural OCT alterations.
FACTORS INFLUENCING THE DELAYED DIAGNOSIS OF STARGARDT DISEASE AND IMPACT ON THERAPEUTIC OPPORTUNITIES.
Li et al.
Retina·Feb 1, 2026
Patients with Stargardt disease experience significant diagnostic delays averaging nearly 11 years from symptom onset to inherited retinal disease specialist evaluation, with intermediate-onset patients facing the longest delays and progressive vision loss during this period.
Comparing Rhegmatogenous and Tractional Retinal Detachment in Regressed Retinopathy of Prematurity: An International, Multicenter Study.
Hsu et al.
Am J Ophthalmol·Feb 1, 2026
In patients with regressed ROP, late-onset retinal detachment is predominantly rhegmatogenous (95%) with favorable surgical outcomes, while tractional detachments require multiple surgeries and have poorer anatomical success rates.
International Consensuses and Guidelines on Diagnosing and Managing Coats Disease by the Academia Retina Internationalis (ARI), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO).
Mahesh et al.
Am J Ophthalmol·Feb 1, 2026
International expert consensus on Coats disease achieved agreement on 92.3% of clinical statements, establishing standardized approaches for classification, diagnosis, and prognosis while identifying remaining controversies in treatment and pathogenesis.
Treating Retinopathy of Prematurity with Dexamethasone Eye Drops: A Difference-in-Differences Study in Sweden Using Register Data.
Gränse et al.
Ophthalmology·Feb 1, 2026
This Swedish register-based study found that topical dexamethasone eye drops significantly reduced the need for traditional ROP treatments (laser or anti-VEGF injections) in preterm infants with type 2 ROP, with treatment rates dropping from 72% to 13% at the intervention site.
EXCISION OF EXTENSIVE SUBRETINAL FIBROSIS ASSOCIATED WITH RHEGMATOGENOUS RETINAL DETACHMENTS IN PATIENTS WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.
Kondo et al.
Retina·Feb 1, 2026
En bloc excision of extensive subretinal fibrosis through wide retinotomy is more effective than piecemeal removal in pediatric FEVR patients with rhegmatogenous retinal detachment, achieving successful reattachment and improved visual outcomes.
The Spectrum of Uveitis and Retinal Vasculitis in Systemic Sclerosis: A Case Series.
Arline et al.
Ocul Immunol Inflamm·Feb 5, 2026
This is the first case series documenting active retinal vasculitis in systemic sclerosis patients, showing that ocular inflammation in this condition predominantly manifests as retinal vascular involvement rather than typical uveitis patterns.
Contribution of Ocular Involvement to the Diagnosis of Systemic Sarcoidosis and Prognostic Significance.
Garcia-Garcia et al.
Ocul Immunol Inflamm·Feb 5, 2026
Ocular sarcoidosis occurs in 13.5% of systemic sarcoidosis patients and is associated with more persistent systemic disease activity and higher rates of central nervous system involvement.
Spectrum of Ocular Manifestations in Anti-Synthetase Syndrome: A Case Report and Systematic Review.
Sriranganathan et al.
Ocul Immunol Inflamm·Feb 5, 2026
This case report describes the first documented case of bilateral panuveitis with occlusive retinal vasculitis in anti-synthetase syndrome, expanding the known spectrum of ocular manifestations beyond the commonly reported dry eye disease.
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trial.
Saadoun et al.
Am J Ophthalmol·Feb 3, 2026
This multicenter randomized trial of 112 patients with active, refractory non-infectious uveitis found that adalimumab and tocilizumab demonstrated comparable efficacy, while anakinra was ineffective and discontinued early.
Treatment Initiation within the Therapeutic Window of Opportunity in Acute Uveitic Phase of Vogt-Koyanagi-Harada Disease Preserves Photoreceptor Function.
Abu El-Asrar et al.
Ocul Immunol Inflamm·Feb 3, 2026
Early immunosuppressive treatment of VKH disease within the therapeutic window of opportunity (before anterior segment inflammation develops) preserves photoreceptor function and prevents sunset glow fundus development.
Sex-Related Effects on the Clinical Presentation of Uveitis.
Samalia et al.
Am J Ophthalmol·Feb 1, 2026
This large retrospective study of 5,703 uveitis patients demonstrates significant sex-based differences in uveitic entities and complications, with females showing higher rates of certain inflammatory conditions and bilateral vision loss.
Assessing the Research Impact of U.S. Academic Uveitis Specialists Using the Relative Citation Ratio.
Franco et al.
Am J Ophthalmol·Feb 1, 2026
A bibliometric analysis of 180 U.S. academic uveitis specialists found median research impact (m-RCR) of 1.28, exceeding the standardized benchmark of 1.0, with significant variation by academic rank and years since residency completion.
Idiopathic Multifocal Choroiditis/Punctate Inner Choroidopathy as a Secondary Inflammatory Reaction to Lacquer Cracks: A Structural and Temporal Analysis.
Cicinelli et al.
Am J Ophthalmol·Feb 1, 2026
This study of 185 eyes with idiopathic multifocal choroiditis/punctate inner choroidopathy (iMFC/PIC) found that 75% had lesions spatially aligned with lacquer cracks, suggesting these inflammatory lesions may represent secondary reactions to mechanical outer retinal disruption in highly myopic eyes rather than purely idiopathic disease.
Clinical Efficacy of Biosimilar Switch of Adalimumab and Infliximab for Noninfectious Uveitis: Systematic Review and Meta-Analysis.
Zhang et al.
Am J Ophthalmol·Feb 1, 2026
Switching from originator to biosimilar TNF-α inhibitors (adalimumab/infliximab) in noninfectious uveitis patients showed clinical equivalence with no significant increase in flare rates or changes in steroid/immunosuppressive use.
Clinical Significance of T-SPOT.TB Test in Patients With Uveitis in South Korea.
Song et al.
Am J Ophthalmol·Feb 1, 2026
In this South Korean cohort of 382 uveitis patients, T-SPOT.TB positivity (32.7%) was not associated with specific uveitis clinical features or treatment patterns, suggesting it may reflect background latent TB infection rather than active ocular involvement.
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry.
Gaggiano et al.
Am J Ophthalmol·Feb 1, 2026
This registry study of 700 patients found that noninfectious uveitis activity varies significantly across female reproductive life stages, with peaks during early puberty and perimenopause that are specific to women.
Association of Migraine With Increased Risk of Central Serous Chorioretinopathy: A Retrospective Cohort Study.
Nitzan et al.
Am J Ophthalmol·Feb 1, 2026
This large retrospective cohort study found that patients with migraine have a 2.74-fold increased risk of developing central serous chorioretinopathy (CSCR) compared to controls, suggesting a potential shared pathophysiologic mechanism.
Evaluating the Effectiveness of Escalating to Weekly Adalimumab Dosing for the Treatment of Noninfectious Uveitis: A Multicenter Study.
Pillar et al.
Ophthalmology·Feb 1, 2026
Weekly adalimumab dosing achieved treatment success in 52% of patients with inadequately controlled noninfectious uveitis, with posterior uveitis showing better outcomes than panuveitis.
EFFICACY AND SAFETY OF SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE IN MIXED ETIOLOGY NONINFECTIOUS CYSTOID MACULAR EDEMA.
Yamamoto et al.
Retina·Feb 1, 2026
Suprachoroidal triamcinolone acetonide injection demonstrated significant anatomical and visual improvements in noninfectious cystoid macular edema of mixed etiologies, with complete resolution in 58.6% of eyes at 1 month and a favorable safety profile.
MULTIMODAL IMAGING AND LONG-TERM TREATMENT OUTCOMES OF RELENTLESS PLACOID CHORIORETINITIS.
Govindaraju et al.
Retina·Feb 1, 2026
This retrospective study of 8 patients (11 eyes) with relentless placoid chorioretinitis demonstrated that all patients achieved disease control with immunosuppressive therapy, with mean visual acuity improving from 20/80 to 20/25.
REAL-WORLD INCIDENCE AND MANAGEMENT OF OCULAR HYPERTENSION AFTER SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE INJECTION FOR MACULAR EDEMA IN NONINFECTIOUS UVEITIS.
Hamdan et al.
Retina·Feb 1, 2026
Real-world study of 76 eyes treated with suprachoroidal triamcinolone acetonide for uveitic macular edema found an 11.8% incidence of ocular hypertension, with prior glaucoma/OHT history being a significant risk factor.
A Novel Staging Model for Uveal Melanoma: Combining Tumor Volume, Clinical Factors, and Genetic Alterations in a Danish Cohort.
Nissen et al.
Ophthalmology·Feb 1, 2026
A novel uveal melanoma staging system combining tumor volume, clinical factors, and genetic alterations provides superior risk stratification compared to traditional anatomical location-based classification systems.
LACK OF COMPLICATIONS OF HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA IN 81 CONSECUTIVE INJECTIONS.
Shields et al.
Retina·Feb 1, 2026
High-dose intravitreal topotecan (90-100 μg) demonstrated 100% safety with no local or systemic complications across 81 consecutive injections in 25 eyes with recurrent retinoblastoma, achieving complete tumor control.
Efficacy of Low-Dose-Rate Iodine-125 Plaque Brachytherapy in the Treatment of Uveal Melanoma.
Cernichiaro-Espinosa et al.
Ophthalmol Retina·Feb 1, 2026
Low-dose-rate Iodine-125 episcleral plaque brachytherapy achieved 93% local control in 1,807 uveal melanoma patients over 38 years, with complication rates comparable to literature reports.
Incidence and Risk Factors for Sympathetic Ophthalmia Following Open Globe Injuries: A Population-Based Analysis.
Bineshfar et al.
Am J Ophthalmol·Feb 1, 2026
Sympathetic ophthalmia occurs in 0.13-0.18% of open globe injuries, with most cases presenting within 6 months, and early enucleation does not significantly reduce risk.
Nonmydriatic Ocular Fundus Imaging on Consecutive Patients Seeking Treatment at a General Emergency Department with Vision Symptoms.
McHenry et al.
Ophthalmology·Feb 1, 2026
Nonmydriatic fundus photography with OCT in a general emergency department identified clinically relevant findings in 64% of patients with vision symptoms, proving most valuable for diagnosing posterior segment and neurologic disorders.
DIRECT POSTERIOR RETINAL INJURY CAUSED BY INTRAVITREAL INJECTIONS: Management and Outcomes From a Vitreoretinal Perspective.
Christou et al.
Retina·Feb 1, 2026
This retrospective case series of 12 eyes documents direct retinal injury from intravitreal injections, showing that while rare, these complications can lead to serious sequelae including retinal detachment with PVR but generally have good outcomes with appropriate management.
MULTICENTER STUDY OF FACTORS ASSOCIATED WITH VISUAL AND ANATOMIC OUTCOMES OF SUPRACHOROIDAL HEMORRHAGE.
Liu et al.
Retina·Feb 1, 2026
This multicenter retrospective study of 143 eyes with suprachoroidal hemorrhage found that visual prognosis remains guarded with mean improvement of 0.41 logMAR at 6 months, while concurrent retinal detachment predicts worse outcomes and systemic steroids may provide modest visual benefit.
Rates of Endophthalmitis in Prefilled versus Nonprefilled Syringes for Intravitreal Injections: A Systematic Review and Meta-Analysis.
Zhang et al.
Ophthalmol Retina·Feb 1, 2026
This systematic review and meta-analysis of 11 studies found that prefilled syringes (both manufacturer-prefilled and pharmacy-compounded) reduce endophthalmitis risk by approximately 47-48% compared to glass vial preparations for intravitreal injections.